Upexi, Inc. (UPXI) is a Nasdaq-listed digital asset treasury company based in Tampa, Florida. Formerly known as Grove, Inc., the firm has shifted from its origins as a consumer-products aggregator to focus primarily on holding Solana. Its main asset is a position of roughly 2.34 million SOL tokens, alongside a smaller consumer-brands segment that includes LuckyTail, PRAX, and Cure Mushrooms. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The strategy involves acquiring and holding Solana, staking for yield, and buying locked tokens at a discount, with about 64% in spot SOL and 36% in locked positions. The company has streamlined operations significantly, reducing headcount from 59 to 10 and outsourcing key functions. This setup makes the stock behave more like a leveraged bet on Solana than a traditional operating business.
In the last 30 days, UPXI declined approximately 33%, moving from near $1.09 down to around $0.72. The drop was sharp, particularly from mid-October, with only minor rebounds along the way. I reviewed comparable names with Tickeron’s AI Pattern Search Engine to put the move in context.
The quarterly view shows a different path but similar net result. Starting near $0.80 in mid-August, the stock climbed to about $1.26 in late September before falling back toward $0.72, leaving it down roughly 10% over three months. This round-trip reflects momentum that faded as Solana prices eased and other concerns resurfaced.
The main factor has been the drop in Solana prices, which directly reduced the value of Upexi’s treasury and amplified the effect through leverage. Share dilution added pressure as the company used at-the-market equity issuance and other transactions to fund token purchases and manage its balance sheet. Fiscal 2026 results highlighted a $246.1 million net loss, largely from a $195.1 million unrealized loss on SOL holdings, along with negative stockholders’ equity of about $53.8 million. The firm also carries roughly $162.4 million in convertible notes that can be settled in SOL.
Additional headwinds came from a Nasdaq listing-compliance notice tied to the share price and an upcoming shareholder vote on a reverse stock split and further share issuance.
The trailing quarter reflected a sentiment swing. Early enthusiasm around Upexi’s Solana treasury approach, supported by investor presentations, drove the late-September rally. That optimism gave way as Solana weakened and investors revisited the balance-sheet picture. The pattern underscores the risks of concentrated exposure to a single volatile asset without diversification.
Solana’s price remains the central variable, influencing both treasury value and solvency through leverage and convertible notes. I’m watching this closely for any shifts in staking yields as well. Corporate developments matter too: the reverse stock split and share issuance vote will affect share count and Nasdaq compliance efforts. Dilution from ongoing financings and progress on debt reduction will also be important. Broader factors like interest-rate expectations, risk appetite for digital assets, and regulatory changes will likely shape the longer-term path.
Tickeron’s AI Screener has become a regular part of how I scan for momentum, valuation, and risk across digital-asset and specialty equities. It lets me apply technical indicators, fundamentals, and performance filters to quickly surface relevant names and compare them efficiently. I find it helpful when evaluating situations like UPXI alongside broader market conditions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
UPXI moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 30 of 31 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The 10-day moving average for UPXI crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UPXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for UPXI entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where UPXI advanced for three days, in 205 of 239 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
UPXI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.976) is normal, around the industry mean (0.974). P/E Ratio (-0.165) is within average values for comparable stocks, (-39.046). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (17.274). Dividend Yield (0.000) settles around the average of (0.979) among similar stocks. P/S Ratio (2.117) is also within normal values, averaging (71.888).
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. UPXI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UPXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InternetSoftwareServices